Webinar
The world may have changed seemingly overnight, but clinical research and medical innovation must continue now more than ever. This webinar, presented on International Clinical Trials Day, discusses how to decentralize your trials in order to keep them going during the COVID-19 pandemic. Decentralized and hybrid clinical trials (DCTs) offer a more patient-centric approach in which fewer clinic visits are required and patient and caregiver burden are reduced. During this time, DCTs are critical to maintain patient safety, data quality and research continuity.
Featuring Craig Lipset, former Head of Clinical Innovation at Pfizer, Kai Langel, Director of Clinical Innovation at Janssen, Paul Bodfish, VP of Corporate Services at the Medical Research Network, and Derk Arts, MD, PhD, Founder and CEO of Castor.
Discover all the features offered by Castor EDC
Discover Now
